,
, Estimations nationales de l'incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Synthèse, 2019.
Quels gènes analyser face à un risque de cancer héréditaire du sein et de l'ovaire ?, 2017. ,
Oncogénétique en 2017 -consultations et laboratoires, Février, 2019. ,
,
, Bull Cancer (Paris). mars, vol.91, issue.3, pp.219-256, 2004.
Cancer du sein -Quelles modalités de dépistage pour quelles femmes ?, 2015. ,
Parcours global des cas index et apparentés en oncogénétique, 2018. ,
Gene-panel sequencing and the prediction of breast-cancer risk, N Engl J Med. 4 juin, vol.372, issue.23, pp.2243-57, 2015. ,
In search of the tumour-suppressor functions of BRCA1 and BRCA2, Nature, vol.23, issue.6811, pp.429-461, 2000. ,
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies, Am J Hum Genet. mai, vol.72, issue.5, pp.1117-1147, 2003. ,
Meta-Analysis of BRCA1 and BRCA2 Penetrance, J Clin Oncol. 10 avr, vol.25, issue.11, pp.1329-1362, 2007. ,
Cancer Risks for BRCA1 ,
, BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE, JNCI J Natl Cancer Inst. 5 juin, vol.105, issue.11, pp.812-834, 2013.
Oncogénétique des cancers pelviens ,
,
,
, Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers, Eur J Hum Genet EJHG, vol.25, issue.12, pp.1345-53, 2017.
A surfeit of RAD51-like genes?, Trends Genet TIG. mai, vol.15, issue.5, pp.166-174, 1999. ,
Evidence for simultaneous protein interactions between human Rad51 paralogs, J Biol Chem. 2 juin, vol.275, issue.22, pp.16443-16452, 2000. ,
RAD51C is a susceptibility gene for ovarian cancer, Hum Mol Genet. 15 août, vol.20, issue.16, pp.3278-88, 2011. ,
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer, J Med Genet. juill, vol.49, issue.7, pp.429-461, 2012. ,
Germline RAD51C mutations confer susceptibility to ovarian cancer, Nat Genet. 26 avr, vol.44, issue.5, pp.475-481, 2012. ,
Germline mutations in RAD51D confer susceptibility to ovarian cancer, Nat Genet. 7 août, vol.43, issue.9, pp.879-82, 2011. ,
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families, J Med Genet. janv, vol.53, issue.1, pp.34-42, 2016. ,
Contribution of ,
URL : https://hal.archives-ouvertes.fr/hal-01460107
, Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population, J Clin Oncol Off J Am Soc Clin Oncol. 10 sept, vol.33, issue.26, pp.2901-2908, 2015.
,
, Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers, J Clin Oncol. 20 juill, vol.33, issue.21, pp.2345-52, 2015.
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, vol.250, issue.4985, pp.1233-1241, 1990. ,
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome, J Med Genet, 2017. ,
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations, Clin Cancer Res. 15 janv, vol.18, issue.2, pp.400-407, 2012. ,
,
, Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients, Hered Cancer Clin Pract. 17 juin, vol.8, issue.1, p.6, 2010.
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families ,
, Gastroenterology. 1 déc, vol.121, issue.6, pp.1348-53, 2001.
,
, Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care, J Clin Oncol Off J Am Soc Clin Oncol. 1 mai, vol.34, issue.13, pp.1455-1464, 2016.
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review, Gastroenterology. mai, vol.371, issue.6, pp.1535-1584, 1993. ,
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome, JAMA. 8 juin, vol.305, issue.22, pp.2304-2314, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00780536
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study, Lancet Oncol. janv, vol.12, issue.1, pp.49-55, 2011. ,
,
, Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat, vol.29, pp.1282-91, 2008.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, On behalf of the ACMG Laboratory Quality Assurance Committee, vol.17, pp.405-428, 2015. ,
,
, Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2, Am J Hum Genet, vol.75, issue.4, pp.535-579, 2004.
,
, Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance, Cancer Res. 15 févr, vol.66, issue.4, pp.2019-2046, 2006.
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes, Am J Hum Genet, vol.81, issue.5, pp.873-83, 2007. ,
Classification of rare missense substitutions, using risk surfaces, with genetic-and molecular-epidemiology applications, Hum Mutat, vol.29, issue.11, pp.1342-54, 2008. ,
A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS), Hum Mutat. janv, vol.33, issue.1, pp.8-21, 2012. ,
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families, Breast Cancer Res Treat. 1 janv, vol.125, issue.1, pp.169-73, 2011. ,
Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families, Lancet Oncol. 1 déc, vol.8, issue.12, pp.1042-1045, 2007. ,
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation, Br J Cancer. janv, vol.100, issue.2, pp.421-426, 2009. ,
BRCA Share: A Collection of Clinical BRCA Gene Variants, Hum Mutat, vol.37, issue.12, pp.1318-1346, 2016. ,
Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases, J Community Genet, vol.6, issue.4, pp.351-360, 2015. ,
BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management, The Oncologist, vol.18, issue.5, pp.518-542, 2013. ,
,
Haute Autorité de santé 2014 -Dépistage du cancer du sein en France : identification des femmes à haut risque et modalités de dépistage Synthèse ,
Synthèse -Femmes porteuses d'une mutation de BRCA1 ou BRCA2 /Détection précoce du cancer du sein et des annexes et stratégies de réduction du risque, 2017. ,
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions, Br J Cancer. 22 avr, vol.98, issue.8, pp.1457-66, 2008. ,
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction, Cancer. 1 févr, vol.73, issue.3, pp.643-51, 1994. ,
,
, BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes, J Clin Oncol Off J Am Soc Clin Oncol. 1 juin, vol.20, issue.11, pp.2701-2713, 2002.
A breast cancer prediction model incorporating familial and personal risk factors, Stat Med. 15 avr, vol.23, issue.7, pp.1111-1141, 2004. ,
Estimation of individual breast cancer risk: relevance and limits of risk estimation models ,
, Bull Cancer (Paris), vol.96, pp.979-88, 2009.
,
, Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers, J Med Genet. sept, vol.46, issue.9, pp.593-600, 2009.
A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer, Gynecol Oncol, vol.112, issue.3, pp.594-600, 2009. ,
BRCAassociated Cancers: Role of Imaging in Screening, Diagnosis, and Management, vol.37, pp.1005-1028, 2017. ,
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study, Br J Cancer. 7 mai, vol.96, issue.9, pp.1335-1377, 2007. ,
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer, N Engl J Med. 14 janv, vol.340, issue.2, pp.77-84, 1999. ,
Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy ,
, JAMA. 19 juill, vol.284, issue.3, pp.319-343, 2000.
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality ,
, JAMA. 1 sept, vol.304, issue.9, pp.967-75, 2010.
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation, Gynecol Oncol. 1 avr, vol.121, issue.1, pp.163-171, 2011. ,
Avantages et désavantages du sondage en ligne comme méthode de collecte de données : une revue de la littérature, vol.21, 2015. ,
Radiation risk from screening mammography of women aged 40-49 years, J Natl Cancer Inst Monogr, vol.22, pp.119-143, 1997. ,
Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers, J Natl Cancer Inst. 4 févr, vol.101, issue.3, pp.205-214, 2009. ,
Chromosomal instability induced by mammography X-rays in primary human fibroblasts from BRCA1 and BRCA2 mutation carriers ,
, Int J Radiat Biol, vol.88, issue.11, pp.846-57, 2012.
Understanding of BRCA VUS genetic results by breast cancer specialists. BMC Cancer, vol.15, p.936, 2015. ,